Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Practical Application of Recent Clinical Data for Immunotherapy in NSCLC
EP. 1: Practical Application of Recent Clinical Data for Immunotherapy in NSCLC
October 10th 2018
EP. 2: Upfront PD-1 Inhibitor Monotherapy in Advanced NSCLC
October 10th 2018
EP. 3: Immunotherapy + Chemotherapy in Nonsquamous NSCLC
October 10th 2018
EP. 4: Combining Chemotherapy & Immunotherapy in Squamous NSCLC
October 10th 2018
EP. 5: TMB as a Predictive Biomarker in NSCLC
October 10th 2018
EP. 6: Treating Relapsed/Refractory NSCLC After I-O Therapy
October 10th 2018
EP. 7: Continuing/Re-Challenging With I-O Therapy in NSCLC
October 10th 2018
EP. 8: Experience With I-O Therapies in Second-Line NSCLC
October 10th 2018
EP. 9: Immunotherapy in Locally Advanced NSCLC
October 10th 2018
EP. 10: Managing Pneumonitis in NSCLC
October 10th 2018
EP. 11: PD-L1 Expression in NSCLC
October 10th 2018
EP. 12: I-O Therapy Versus Surgery or Chemotherapy in NSCLC
October 10th 2018
EP. 13: Immunotherapy in NSCLC: Audience Q&A
October 10th 2018
x